General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Transcriptional addiction in cancer
Reduced Glutathione | 450mg
Bcl-2 and Bcl-xl are expressed in higher levels in poor prognosis (monosomy 5 and monosomy 7) acute myeloid leukemia AML) cells than in good prognosis [inversion 16 and t(8;21)] AML cells
Clinical Update 5/28/2025 Zyflamend for Joint Health We recently tested Zyflamend , a supplement promoted for pain relief and joint support
GHRPs (growth hormone-releasing peptides) like Ipamorelin are ghrelin mimetics that activate the GHS-R receptor, a different receptor pathway that also triggers GH release